Furthermore, also isoform-specific IL-1 inhibition by mean of anti-IL-1β and anti-IL-1α neutralizing antibodies was shown to reduce inflammasome activation and preserve left-ventricular systolic function [227, 228], even if administered after ischemia [159]. Here, IL1A is linked to ischemia.